Advertisement

Der Nervenarzt

, Volume 80, Issue 10, pp 1239–1251 | Cite as

Neuroborreliose

  • R. Kaiser
  • V. Fingerle
CME - Weiterbildung - Zertifizierte Fortbildung

Zusammenfassung

Die Neuroborreliose ist klinisch und laborchemisch meist gut zu diagnostizieren. Leitsymptome sind radikuläre Schmerzen sowie Paresen der Extremitäten und des N. facialis. Die Vielzahl weiterer seltener neurologischer Symptome lässt sich durch die Liquoranalyse in der Regel gut zuordnen. Die Therapie mit Doxycyclin (oral), Cephalosporinen der 3. Generation (Ceftriaxon, Cefotaxim) oder Penicillin G (i.v.) orientiert sich an der klinischen Symptomatik (zentral, peripher). Das Post-Lyme-Syndrom ist eine diffuse Beschreibung unspezifischer Beschwerden, die keine sichere Kausalität mit einer vorausgegangen Borrelieninfektion aufweisen. Die Pathogenese ist unklar, eine Erregerpersistenz kann, bei unauffälligem Liquor und fehlendem Behandlungserfolg von Antibiotika in gut geplanten Studien, weitestgehend ausgeschlossen werden.

Schlüsselwörter

Neuroborreliose Bannwarth-Syndrom Meningopolyneuritis Borrelia 

Neuroborreliosis

Summary

Neuroborreliosis is easily diagnosed by means of clinical symptoms and laboratory findings. Guiding symptoms are radicular pain and pareses of the extremities and the facial nerve. There is a great number of further less frequently occurring neurological symptoms, which can be attributed to a borrelial infection only by appropriate investigations of the CSF. Radiculitis is cured adequately by oral doxycycline while symptoms of the central nervous system are probably better treated intravenously by ceftriaxone, cefotaxime or penicillin G. Post-Lyme syndrome is a diffuse description of non-specific complaints, which are not the explicit result of a former infection with B. burgdorferi. As further antibiotics do not help and the CSF is unremarkable in most patients, a persistent infection with B. burgdorferi s.l. in all probability can be excluded.

Keywords

Neuroborreliosis Bannwarth’s syndrome Meningopolyneuritis Borrelia 

Notes

Interessenkonflikt

Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.

Literatur

  1. 1.
    Benke T, Gasse T, Hittmair-Delazer M, Schmutzhard E (1995) Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 91:353–357CrossRefPubMedGoogle Scholar
  2. 2.
    Brorson O, Brorson SH (1997) Transformation of cystic forms of borrelia burgdorferi to normal, mobile spirochetes. Infection 25:240–246CrossRefPubMedGoogle Scholar
  3. 3.
    Bujak DI, Weinstein A, Dornbush RL (1996) Clinical and neurocognitive features of the post Lyme syndrome. J Rheumatol 23:1392–1397PubMedGoogle Scholar
  4. 4.
    Bunikis J, Barbour AG (2002) Laboratory testing for suspected Lyme disease. Med Clin North Am 86:311–340CrossRefPubMedGoogle Scholar
  5. 5.
    Carod AF, Perez L, Gracia NM, Giron MJ (1994) Failure of empirical treatment with ceftriaxone in motor neuron disease. Fracaso del tratamiento empirico con ceftriaxona en la enfermedad de la motoneurona. Neurologia 9:29–31Google Scholar
  6. 6.
    Christen HJ (1996) Lyme neuroborreliosis in children. Ann Med 28:235–240CrossRefPubMedGoogle Scholar
  7. 7.
    Christen HJ, Bartlau N, Hanefeld F et al (1990) Peripheral facial palsy in childhood–Lyme borreliosis to be suspected unless proven otherwise. Acta Paediatr Scand 79:1219–1224PubMedGoogle Scholar
  8. 8.
    Coyle PK (2000) Chronic meningitis. Curr Treat Options Neurol 2(4):375–387CrossRefPubMedGoogle Scholar
  9. 9.
    Coyle PK, Schutzer SE (2002) Neurologic aspects of Lyme disease. Med Clin North Am 86:261–284CrossRefPubMedGoogle Scholar
  10. 10.
    Dotevall L, Hagberg L (1989) Penetration of doxycycline into cerebrospinal fluid in patients treated for suspected Lyme neuroborreliosis. Antimicrob Agents Chemother 33:1078–1080PubMedGoogle Scholar
  11. 11.
    Dotevall L, Hagberg L (1999) Successful oral doxycycline treatment of Lyme disease-associated facial palsy and meningitis. Clin Infect Dis 28:569–574CrossRefPubMedGoogle Scholar
  12. 12.
    Elkins LE, Pollina DA, Scheffer SR, Krupp LB (1999) Psychological states and neuropsychological performances in chronic Lyme disease. Appl Neuropsychol 6:19–26CrossRefPubMedGoogle Scholar
  13. 13.
    Fallon BA, Nields JA (1994) Lyme disease: a neuropsychiatric illness. Am J Psychiatry 151:1571–1583PubMedGoogle Scholar
  14. 14.
    Fallon BA, Nields JA, Parsons B et al (1993) Psychiatric manifestations of Lyme borreliosis. J Clin Psychiatry 54:263–268PubMedGoogle Scholar
  15. 15.
    Fingerle V, Schulte-Spechtel UC, Ruzic-Sabljic E et al (2008) Epidemiological aspects and molecular characterization of borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov. Int J Med Microbiol 298:279–290CrossRefPubMedGoogle Scholar
  16. 16.
    Finizia C, Jonsson R, Hanner P (2001) Serum and cerebrospinal fluid pathology in patients with sudden sensorineural hearing loss. Acta Otolaryngol 121:823–830CrossRefPubMedGoogle Scholar
  17. 17.
    Gutacker M, Valsangiacomo C, Balmelli T et al (1998) Arguments against the involvement of borrelia burgdorferi sensu lato in alzheimer’s disease. Res Microbiol 149:31–37CrossRefPubMedGoogle Scholar
  18. 18.
    Halperin JJ, Kaplan GP, Brazinsky S et al (1990) Immunologic reactivity against borrelia burgdorferi in patients with motor neuron disease. Arch Neurol 47:586–594PubMedGoogle Scholar
  19. 19.
    Halperin JJ, Shapiro ED, Logigian E et al (2007) Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 69:91–102CrossRefPubMedGoogle Scholar
  20. 20.
    Heller J, Holzer G, Schimrigk K (1990) Immunological differentiation between neuroborreliosis and multiple sclerosis. J Neurol 237:465–470CrossRefPubMedGoogle Scholar
  21. 21.
    Holmgren AR, Matteson EL (2006) Lyme myositis. Arthritis Rheum 54:2697–2700CrossRefPubMedGoogle Scholar
  22. 22.
    Jacobi C, Schwark C, Kress B et al (2006) Subarachnoid hemorrhage due to borrelia burgdorferi-associated vasculitis. Eur J Neurol 13:536–538CrossRefPubMedGoogle Scholar
  23. 23.
    Kaiser R (1994) Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients. J Neurol 242:26–36CrossRefPubMedGoogle Scholar
  24. 24.
    Kaiser R (2004) Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone. Nervenarzt 75:553–557CrossRefPubMedGoogle Scholar
  25. 25.
    Kaiser R, Lucking CH (1993) Intrathecal synthesis of specific antibodies in neuroborreliosis. Comparison of different ELISA techniques and calculation methods. J Neurol Sci 118:64–72CrossRefPubMedGoogle Scholar
  26. 26.
    Kaplan RF, Jones-Woodward L (1997) Lyme encephalopathy: a neuropsychological perspective. Semin Neurol 17:31–37CrossRefPubMedGoogle Scholar
  27. 27.
    Kaplan RF, Meadows ME, Vincent LC et al (1992) Memory impairment and depression in patients with Lyme encephalopathy: comparison with fibromyalgia and nonpsychotically depressed patients. Neurology 42:1263–1267PubMedGoogle Scholar
  28. 28.
    Kaplan RF, Trevino RP, Johnson GM et al (2003) Cognitive function in post-treatment Lyme disease: do additional antibiotics help? Neurology 60:1916–1922PubMedGoogle Scholar
  29. 29.
    Karkkonen K, Stiernstedt SH, Karlsson M (2001) Follow-up of patients treated with oral doxycycline for Lyme neuroborreliosis. Scand J Infect Dis 33:259–262CrossRefPubMedGoogle Scholar
  30. 30.
    Kindstrand E, Nilsson BY, Hovmark A et al (2000) Polyneuropathy in late lyme borreliosis – a clinical, neurophysiological and morphological description. Acta Neurol Scand 101(1):47–52CrossRefPubMedGoogle Scholar
  31. 31.
    Klempner MS, Hu LT, Evans J et al (2001) Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease. N Engl J Med 345:85–92CrossRefPubMedGoogle Scholar
  32. 32.
    Kraemer JD, Gostin LO (2009) Science, politics and values: the politicization of professional practice guidelines. JAMA 301:665–667CrossRefPubMedGoogle Scholar
  33. 33.
    Kristoferitsch W, Baumhackl U, Sluga E et al (1987) High-dose penicillin therapy in meningopolyneuritis Garin-Bujadoux-Bannwarth. Clinical and cerebrospinal fluid data. Zentralbl Bakteriol Mikrobiol Hyg (A) 263:357–364Google Scholar
  34. 34.
    Kruger H, Reuss K, Pulz M et al (1989) Meningoradiculitis and encephalomyelitis due to Borrelia burgdorferi: a follow-up study of 72 patients over 27 years. J Neurol 236:322–328CrossRefPubMedGoogle Scholar
  35. 35.
    Krupp LB, Hyman LG, Grimson R et al (2003) Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial. Neurology 60:1923–1930PubMedGoogle Scholar
  36. 36.
    Krupp LB, Masur D, Schwartz J et al (1991) Cognitive functioning in late Lyme borreliosis. Arch Neurol 48:1125–1129PubMedGoogle Scholar
  37. 37.
    Lebech AM (2002) Polymerase chain reaction in diagnosis of Borrelia burgdorferi infections and studies on taxonomic classification. APMIS Suppl 1–40Google Scholar
  38. 38.
    Ljostad U, Mygland A (2008) CSF B–lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis. J Neurol 255:732–737CrossRefPubMedGoogle Scholar
  39. 39.
    Ljostad U, Skogvoll E, Eikeland R et al (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7:690–695CrossRefPubMedGoogle Scholar
  40. 40.
    Logigian EL, Kaplan RF, Steere AC (1990) Chronic neurologic manifestations of Lyme disease. N Engl J Med 323:1438–1444PubMedGoogle Scholar
  41. 41.
    Magid D, Schwartz B, Craft J, Schwartz JS (1992) Prevention of Lyme disease after tick bites. A cost-effectiveness analysis. N Engl J Med 327:534–541PubMedCrossRefGoogle Scholar
  42. 42.
    Maiwald M, Oehme R, March O et al (1998) Transmission risk of Borrelia burgdorferi sensu lato from Ixodes ricinus ticks to humans in southwest Germany. Epidemiol Infect 121:103–108CrossRefPubMedGoogle Scholar
  43. 43.
    Marques AR, Weir SC, Fahle GA, Fischer SH (2000) Lack of evidence of Borrelia involvement in Alzheimer’s disease. J Infect Dis 182(3):1006–1007CrossRefPubMedGoogle Scholar
  44. 44.
    Meer-Scherrer L, Chang LC, Adelson ME et al (2006) Lyme disease associated with Alzheimer’s disease. Curr Microbiol 52:330–332CrossRefPubMedGoogle Scholar
  45. 45.
    Meier C, Grahmann F, Engelhardt A, Dumas M (1989) Peripheral nerve disorders in Lyme-Borreliosis. Nerve biopsy studies from eight cases. Acta Neuropathol 79:271–278CrossRefPubMedGoogle Scholar
  46. 46.
    Miklossy J (2008) Chronic inflammation and amyloidogenesis in Alzheimer’s disease – role of spirochetes. J Alzheimers Dis 13:381–391PubMedGoogle Scholar
  47. 47.
    Mygland A, Skarpaas T, Ljostad U (2006) Chronic polyneuropathy and Lyme disease. Eur J Neurol 13:1213–1215CrossRefPubMedGoogle Scholar
  48. 48.
    Oksi J, Nikoskelainen J, Hiekkanen H et al (2007) Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study. Eur J Clin Microbiol Infect Dis 26:571–581CrossRefPubMedGoogle Scholar
  49. 49.
    Pappolla MA, Omar R, Saran B et al (1989) Concurrent neuroborreliosis and Alzheimer’s disease: analysis of the evidence. Hum Pathol 20:753–757CrossRefPubMedGoogle Scholar
  50. 50.
    Peltomaa M, Pyykko I, Sappala I et al (2000) Lyme borreliosis, an etiological factor in sensorineural hearing loss? Eur Arch Otorhinolaryngol 257(6):317–322CrossRefPubMedGoogle Scholar
  51. 51.
    Peltomaa M, Pyykko I, Seppala I, Viljanen M (1998) Lyme borreliosis–an unusual cause of vertigo. Auris Nasus Larynx 25:233–242CrossRefPubMedGoogle Scholar
  52. 52.
    Pfister HW, Einhaupl KM, Wilske B, Preac-Mursic V (1987) Bannwarth’s syndrome and the enlarged neurological spectrum of arthropod-borne borreliosis. Zentralbl Bakteriol Mikrobiol Hyg (A) 263:343–347Google Scholar
  53. 53.
    Piesman J, Mather TN, Sinsky RJ, Spielman A (1987) Duration of tick attachment and Borrelia burgdorferi transmission. J Clin Microbiol 25:557–558PubMedGoogle Scholar
  54. 54.
    Porcella SF, Schwan TG (2001) Borrelia burgdorferi and treponema pallidum: a comparison of functional genomics, environmental adaptations and pathogenic mechanisms. J Clin Invest 107:651–656CrossRefPubMedGoogle Scholar
  55. 55.
    Rauer S, Kaiser R, Kölmel W et al (2008) Neuroborreliose. In Diener HC, Putzki N (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. Thieme, Stuttgart, NY S 415–424Google Scholar
  56. 56.
    Reimer B, Erbas B, Lobbichler K et al (2002) Seroprevalence of Borrelia infection in occupational tick-exposed people in Bavaria (Germany). Int J Med Microbiol 291 [Suppl 33]:215Google Scholar
  57. 57.
    Reimers CD, de Koning J, Neubert U et al (1993) Borrelia burgdorferi myositis: report of eight patients. J Neurol 240:278–283CrossRefPubMedGoogle Scholar
  58. 58.
    Rupprecht TA, Elstner M, Weil S, Pfister HW (2008) Autoimmune-mediated polyneuropathy triggered by borrelial infection? Muscle Nerve 37:781–785CrossRefPubMedGoogle Scholar
  59. 59.
    Rupprecht TA, Koedel U, Angele B et al (2006) Cytokine CXCL13–a possible early CSF marker for neuroborreliosis. Nervenarzt 77:470–473CrossRefPubMedGoogle Scholar
  60. 60.
    Rupprecht TA, Koedel U, Fingerle V, Pfister HW (2008) The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol Med 14:205–212PubMedGoogle Scholar
  61. 61.
    Schafers M, Neukirchen S, Toyka KV, Sommer C (2008) Diagnostic value of sural nerve biopsy in patients with suspected Borrelia neuropathy. J Peripher Nerv Syst 13:81–91CrossRefPubMedGoogle Scholar
  62. 62.
    Schmutzhard E (2002) Multiple sclerosis and Lyme borreliosis. Wien Klin Wochenschr 114:539–543PubMedGoogle Scholar
  63. 63.
    Schmutzhard E, Stanek G, Pletschette M et al (1988) Infections following tickbites. Tick-borne encephalitis and Lyme borreliosis–a prospective epidemiological study from tyrol. Infection 16:269–272CrossRefPubMedGoogle Scholar
  64. 64.
    Steere AC (1989) Lyme disease. N Engl J Med 321:586–596PubMedGoogle Scholar
  65. 65.
    Wilske B (2002) Microbiological diagnosis in Lyme borreliosis. Int J Med Microbiol 291 [Suppl 33]:114–119Google Scholar
  66. 66.
    Wilske B, Fingerle V, Schulte-Spechtel U (2007) Microbiological and serological diagnosis of Lyme borreliosis. FEMS Immunol Med Microbiol 49:13–21CrossRefPubMedGoogle Scholar
  67. 67.
    Wormser GP, Dattwyler RJ, Shapiro ED et al (2006) The clinical assessment, treatment and prevention of lyme disease, human granulocytic anaplasmosis and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43:1089–1134CrossRefPubMedGoogle Scholar

Copyright information

© Springer Medizin Verlag 2009

Authors and Affiliations

  1. 1.Neurologische KlinikKlinikum PforzheimPforzheimDeutschland
  2. 2.Konsiliarlabor für Ehrlichien, Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL), Dienststelle OberschleißheimNationales Referenzzentrum für BorrelienOberschleißheimDeutschland

Personalised recommendations